PneumoNIX Medical, Inc. (PMI)

Developing biopsy track sealants. $709 M market WW. $3.6 M in grants rec'd, of which $1 million remains. Raising $1.5 million. Exit expected in 2026.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Boston, MA, USA
  • Currency USD
  • Founded July 2018
  • Employees 4
  • Incorporation Type C-corp
  • Website pneumonix.com

Company Summary

Patients that undergo a biopsy (e.g., lung & kidney) will bleed or develop an air leak that delays hospital discharge and may even require an overnight stay. PreVENT, eliminates complications by sealing the biopsy track. We have raised $3.6 million in grants from the NIH and the NSF, of which about $1 million remains to be spent. The company is raising $1.5 million in a Series A round at $2.00 per share, which is an $8 million pre-money value.

Team

  • James Wilkie
    CEO

    James Wilkie - 38 years in biotech developing both drugs & devices. Previously CEO of Lowell Therapeutics, acquired by AcelRx in 2022. He was a VP at La Jolla Pharmaceutical Co. where he identified new drug candidates. Prior to LJPC, he was COO of Pluromed, acquired by Sanofi in 2012. Prior to Pluromed, he was the Director of Eng. at MedChem Products, Inc. until the sale to Bard. Jim received his B.S. from the Univ. of Mass. in 1985.

  • Wade Schutte
    Co-Founder

    Wade Schutte works in Business Development CRDN, Structural Heart, Cardiac Surgery in Medtronic’s cardiovascular businesses. He has significant experience examining patents at the USPTO. Wade earned his MS in Bioengineering Innovation and Design from Johns Hopkins University.

  • Shash Gupta
    Co-Founder

    Shash Gupta developed and marketed interventional radiology and oncology therapies at Boston Scientific and IZI Medical. Shash earned his MS in Bioengineering Innovation and Design from Johns Hopkins University.

  • Andrew Eisenthal
    Co-Founder

    Dr. Eisenthal earned his MD from Columbia University College of Physicians & Surgeons.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free